A number of studies have demonstrated that key pathways which regulate major metabolic functions, such as PI3K/Akt/mTOR, MAPK/MNK, and AMPK pathways, are deregulated in cancers including in gliomas. This evidence concerns the gene MTOR and central nervous system cancer.